291 related articles for article (PubMed ID: 9183767)
21. Effect of the alpha-glucosidase inhibitor acarbose on control of glycemia in dogs with naturally acquired diabetes mellitus.
Nelson RW; Robertson J; Feldman EC; Briggs C
J Am Vet Med Assoc; 2000 Apr; 216(8):1265-9. PubMed ID: 10767967
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of serum fructosamine concentration as an index of blood glucose control in cats with diabetes mellitus.
Kaneko JJ; Kawamoto M; Heusner AA; Feldman EC; Koizumi I
Am J Vet Res; 1992 Oct; 53(10):1797-801. PubMed ID: 1456523
[TBL] [Abstract][Full Text] [Related]
23. Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995).
Goossens MM; Nelson RW; Feldman EC; Griffey SM
J Vet Intern Med; 1998; 12(1):1-6. PubMed ID: 9503353
[TBL] [Abstract][Full Text] [Related]
24. Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine.
Hall TD; Mahony O; Rozanski EA; Freeman LM
J Feline Med Surg; 2009 Feb; 11(2):125-30. PubMed ID: 18835801
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes.
Mu J; Petrov A; Eiermann GJ; Woods J; Zhou YP; Li Z; Zycband E; Feng Y; Zhu L; Roy RS; Howard AD; Li C; Thornberry NA; Zhang BB
Eur J Pharmacol; 2009 Nov; 623(1-3):148-54. PubMed ID: 19765579
[TBL] [Abstract][Full Text] [Related]
26. Food intake and blood glucose in normal and diabetic cats fed ad libitum.
Martin GJ; Rand JS
J Feline Med Surg; 1999 Dec; 1(4):241-51. PubMed ID: 11714241
[TBL] [Abstract][Full Text] [Related]
27. Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM.
Pecoraro RE; Chen MS; Porte D
Diabetes Care; 1982; 5(6):592-9. PubMed ID: 6927729
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
[TBL] [Abstract][Full Text] [Related]
29. Glycosylated haemoglobin levels in patients referred for oral glucose tolerance tests.
John WG; Richardson RW
Diabet Med; 1986 Jan; 3(1):46-8. PubMed ID: 2951135
[TBL] [Abstract][Full Text] [Related]
30. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
[TBL] [Abstract][Full Text] [Related]
31. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus.
Alt N; Kley S; Tschuor F; Zapf J; Reusch CE
Res Vet Sci; 2007 Dec; 83(3):331-5. PubMed ID: 17367830
[TBL] [Abstract][Full Text] [Related]
33. Insulin sensitivity in normal and diabetic cats.
Feldhahn JR; Rand JS; Martin G
J Feline Med Surg; 1999 Jun; 1(2):107-15. PubMed ID: 11919024
[TBL] [Abstract][Full Text] [Related]
34. Effects of short-term insulin therapy upon therapeutic response to glipizide.
Schwartz SL; Fischer JS; Kipnes MS; Boyle M
Am J Med; 1987 Sep; 83(3A):22-30. PubMed ID: 3307403
[TBL] [Abstract][Full Text] [Related]
35. Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension.
Martin GJ; Rand JS
Vet Rec; 2007 Jul; 161(2):52-8. PubMed ID: 17630418
[TBL] [Abstract][Full Text] [Related]
36. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release.
Krämer AL; Riederer A; Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Lutz TA; Contiero B; Zini E; Reusch CE
J Vet Intern Med; 2020 Nov; 34(6):2287-2295. PubMed ID: 33001499
[TBL] [Abstract][Full Text] [Related]
37. Comparison of a continuous glucose monitoring system with a portable blood glucose meter to determine insulin dose in cats with diabetes mellitus.
Dietiker-Moretti S; Müller C; Sieber-Ruckstuhl N; Tschuor F; Osto M; Franchini M; Ackermann M; Lutz TA; Reusch CE; Zini E
J Vet Intern Med; 2011; 25(5):1084-8. PubMed ID: 21985140
[TBL] [Abstract][Full Text] [Related]
38. [Glycosylated hemoglobin in the diagnosis of diabetes mellitus].
Tian H; Lian J; Zhang X
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Jun; 21(2):197-200. PubMed ID: 2391104
[TBL] [Abstract][Full Text] [Related]
39. Effect of glimepiride and nateglinide on serum insulin and glucose concentration in healthy cats.
Mori A; Lee P; Yamashita T; Nishimaki Y; Oda H; Saeki K; Miki Y; Mizutani H; Ishioka K; Honjo T; Arai T; Sako T
Vet Res Commun; 2009 Dec; 33(8):957-70. PubMed ID: 19728131
[TBL] [Abstract][Full Text] [Related]
40. Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.
Riederer A; Zini E; Salesov E; Fracassi F; Padrutt I; Macha K; Stöckle TM; Lutz TA; Reusch CE
J Vet Intern Med; 2016; 30(1):92-100. PubMed ID: 26700409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
